BIZZOTTO, ROBERTO
 Distribuzione geografica
Continente #
AS - Asia 4.218
NA - Nord America 1.149
EU - Europa 691
SA - Sud America 691
AF - Africa 201
Continente sconosciuto - Info sul continente non disponibili 96
OC - Oceania 3
Totale 7.049
Nazione #
SG - Singapore 2.564
US - Stati Uniti d'America 948
BR - Brasile 420
CN - Cina 271
IT - Italia 190
HK - Hong Kong 172
TR - Turchia 148
DE - Germania 134
VN - Vietnam 128
IN - India 118
BD - Bangladesh 93
IQ - Iraq 92
RU - Federazione Russa 90
MX - Messico 88
VE - Venezuela 79
PH - Filippine 77
UZ - Uzbekistan 65
SA - Arabia Saudita 64
MY - Malesia 61
UA - Ucraina 61
FR - Francia 60
MA - Marocco 52
KE - Kenya 49
KR - Corea 48
AR - Argentina 47
ID - Indonesia 47
JP - Giappone 46
IR - Iran 42
CO - Colombia 34
UY - Uruguay 34
JM - Giamaica 32
PY - Paraguay 31
JO - Giordania 29
NL - Olanda 28
AZ - Azerbaigian 27
EC - Ecuador 26
ZA - Sudafrica 26
HN - Honduras 25
KZ - Kazakistan 24
MM - Myanmar 24
EG - Egitto 21
FI - Finlandia 21
GB - Regno Unito 21
CR - Costa Rica 19
NP - Nepal 18
AL - Albania 17
CA - Canada 17
PL - Polonia 16
DZ - Algeria 14
GE - Georgia 12
BO - Bolivia 11
PA - Panama 11
TN - Tunisia 11
BG - Bulgaria 9
CI - Costa d'Avorio 9
ES - Italia 9
AM - Armenia 8
KG - Kirghizistan 8
PK - Pakistan 8
CL - Cile 7
AT - Austria 6
BH - Bahrain 6
RS - Serbia 5
SN - Senegal 5
GT - Guatemala 4
IL - Israele 4
TW - Taiwan 4
XK - ???statistics.table.value.countryCode.XK??? 4
BY - Bielorussia 3
CG - Congo 3
LV - Lettonia 3
TH - Thailandia 3
AE - Emirati Arabi Uniti 2
AU - Australia 2
DK - Danimarca 2
EE - Estonia 2
GA - Gabon 2
GH - Ghana 2
LT - Lituania 2
PT - Portogallo 2
RO - Romania 2
SE - Svezia 2
UG - Uganda 2
AD - Andorra 1
AG - Antigua e Barbuda 1
BE - Belgio 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
CM - Camerun 1
CW - ???statistics.table.value.countryCode.CW??? 1
DJ - Gibuti 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GI - Gibilterra 1
GR - Grecia 1
GY - Guiana 1
HT - Haiti 1
KW - Kuwait 1
LB - Libano 1
LU - Lussemburgo 1
Totale 6.950
Città #
Singapore 2.371
Santa Clara 283
Hong Kong 172
Dallas 126
Frankfurt am Main 115
Hefei 114
Ashburn 96
San Jose 70
Tashkent 59
Beijing 51
Istanbul 46
Lauterbourg 45
Nairobi 45
Seoul 45
Tokyo 43
Ho Chi Minh City 37
Hanoi 32
Jeddah 31
São Paulo 31
Kuala Lumpur 30
Amman 28
Montevideo 27
Milan 26
Baghdad 25
Rome 25
Baku 24
North Bergen 24
Caracas 23
Los Angeles 21
Riyadh 18
Kingston 17
New York 17
Asunción 16
El Progreso 16
Quezon City 16
Rio de Janeiro 16
Casablanca 14
Erbil 14
Maracaibo 14
San José 14
Helsinki 13
Padova 13
Jakarta 12
Moscow 12
Tbilisi 12
Tirana 12
Curitiba 11
Duhok 11
Yangon 11
Brooklyn 10
Izmir 10
New Delhi 10
Quito 10
Abidjan 9
Orem 9
Panama City 9
Belo Horizonte 8
Bengaluru 8
Biên Hòa 8
Genoa 8
Guarulhos 8
Kathmandu 8
Ludhiana 8
Phoenix 8
Almaty 7
Ankara 7
Assago 7
Chennai 7
Coro 7
Johannesburg 7
Lappeenranta 7
Manila 7
Tangier 7
Bishkek 6
Brasília 6
Cape Town 6
Ciudad del Este 6
Council Bluffs 6
Dammam 6
Dhaka 6
Florence 6
Haiphong 6
Hải Dương 6
Kyiv 6
La Paz 6
Medellín 6
Rabat 6
Sulaymaniyah 6
Valencia 6
Warsaw 6
Adana 5
Atlanta 5
Bari 5
Bogotá 5
Cairo 5
Chicago 5
Dakar 5
Guayaquil 5
Houston 5
Hyderabad 5
Totale 4.690
Nome #
Discovery of drug-omics associations in type 2 diabetes with generative deep-learning models 4.808
The Association of Cardiometabolic, Diet and Lifestyle Parameters With Plasma Glucagon-like Peptide-1: An IMI DIRECT Study 112
Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials 110
A reference map of potential determinants for the human serum metabolome 94
Role of human plasma metabolites in prediabetes and type 2 diabetes from the IMI-DIRECT study 85
Processes Underlying Glycemic Deterioration in Type 2 Diabetes: An IMI DIRECT Study 79
Author Correction: Discovery of drug–omics associations in type 2 diabetes with generative deep-learning models (Nature Biotechnology, (2023), 41, 3, (399-408), 10.1038/s41587-022-01520-x) 78
Lipid-induced glucose intolerance is driven by impaired glucose kinetics and insulin metabolism in healthy individuals 74
Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: An IMI DIRECT study 72
Inhibition of sweet chemosensory receptors alters insulin responses during glucose ingestion in healthy adults: A randomized crossover interventional study 71
Genetic studies of abdominal MRI data identify genes regulating hepcidin as major determinants of liver iron concentration 65
Genetic analysis of blood molecular phenotypes reveals common properties in the regulatory networks affecting complex traits 63
Development and optimization of a fentanyl pharmacokinetic model for target-controlled infusion in anaesthetized dogs 61
At any Level of Adiposity, Relatively Elevated Leptin Concentrations Are Associated With Decreased Insulin Sensitivity 61
New insights on the interactions between insulin clearance and the main glucose homeostasis mechanisms 60
Pharmacometrics Markup Language (PharmML): Opening new perspectives for model exchange in drug development 58
Mixed meal ingestion diminishes glucose excursion in comparison with glucose ingestion via several adaptive mechanisms in people with and without type 2 diabetes 57
The influence of metformin treatment on the circulating proteome 57
Drug Effects on Sleep Data from a 28-Day Clinical Study in Insomniac Patients: Covariate Analysis Using a Multinomial Mixed-Effect Markov-Chain Mode 56
Mathematical Modeling for the Physiological and Clinical Investigation of Glucose Homeostasis and Diabetes 50
Dietary metabolite profiling brings new insight into the relationship between nutrition and metabolic risk: An IMI DIRECT study 50
Model description language (MDL): A standard for modeling and simulation 49
Glucose uptake saturation explains glucose kinetics profiles measured by different tests 48
Analysis of variability in length of sleep state bouts reveals memory-free sleep subcomponents consistent among primary insomnia patients 47
A pharmacokinetic model optimized by covariates for propofol target-controlled infusion in dogs 47
Effect of single-dose DPP-4 inhibitor sitagliptin on beta-cell function and incretin hormone secretion after meal ingestion in healthy volunteers and drug-naïve, well-controlled type 2 diabetes subjects 42
Glucose sensitivity, insulin sensitivity and their longitudinal changes are strong independent determinants of type 2 diabetes progression: an IMI DIRECT study 40
PharmML in action: An interoperable language for modeling and simulation 39
Incretin and islet hormone responses to meals of increasing size in healthy subjects 36
Shift to fatty substrate utilization in response to sodium-glucose cotransporter 2 inhibition in subjects without diabetes and patients with type 2 diabetes 36
GLP-1 response to sequential mixed meals: Influence of insulin resistance 34
Adaptation of beta cell response to carbohydrate loading: influence of insulin resistance 34
A single mechanism underlies glucose kinetics in euglycaemic and hyperglycaemic clamps and oral glucose tolerance tests 33
Multinomial logistic functions in markov chain models of sleep architecture: internal and external validation and covariate analysis 31
Sleeping oxygen saturation, rapid eye movement sleep, and the adaptation of postprandial metabolic function in insulin sensitive and resistant individuals without diabetes 31
Adaptation of Beta-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin Resistance 31
Multinomial Markov-chain model of sleep architecture in Phase-Advanced Subjects 31
Characterization of binding between OSM and mAb in RA patient study: an extension to TMDD models 31
Quantitative Assessment of First Night Effect in a Polysomnographic Insomnia Study through a Multinomial Mixed-Effect Markov-Chain Model 29
Increased insulin clearance in mice with double deletion of glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide receptors 29
Glucose Homeostasis Modeling: Improvement of the Insulin Action Component 28
A Target-Mediated Drug Disposition model to quantify the relationship between Anti-CD3 monoclonal antibody and CD3/TCR receptors in Patients with autoimmune diseases 28
Glucose Homeostasis Modeling: Improvement of the Insulin Kinetics Component 26
PK-PD modelling of aOSM in RA patient study including exploration of carrier protein effect 24
Multinomial logistic estimation of Markov-chain models for modeling sleep architecture in primary insomnia patients 24
Totale 7.049
Categoria #
all - tutte 12.597
article - articoli 11.524
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 24.121


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2024/20252.665 22 2 39 32 250 69 48 31 122 589 740 721
2025/20264.201 823 950 1.053 611 147 43 176 49 64 89 74 122
2026/2027183 77 47 59 0 0 0 0 0 0 0 0 0
Totale 7.049